Coya Therapeutics (COYA) insider buying

Healthcare · Biotechnology · Market cap $127M

3 open-market purchases of COYA by Coya Therapeutics's executives and directors since November 2024, worth $69,615 in total, from SEC Form 4 filings.

The most recent: David S Snyder bought $12,942 on November 14, 2024.

The biggest buyer over the period is Arun Swaminathan: 1 purchase, $36,700.

By year

YearPurchasesValue
20243$69,615

Biggest buyers

InsiderBuysValue
Arun Swaminathan
1$36,700
Fred Grossman
1$19,973
David S Snyder
1$12,942

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Nov 14, 2024 David S Snyder
 1,800$7.19$12,942 Form 4
Nov 11, 2024 Arun Swaminathan
 5,000$7.34$36,700 Form 4
Nov 11, 2024 Fred Grossman
 2,710$7.37$19,973 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for COYA.
Open COYA in Investingly

Questions

Are Coya Therapeutics insiders buying the stock?

3 open-market purchases of COYA by Coya Therapeutics's executives and directors since November 2024, worth $69,615 in total, from SEC Form 4 filings. The most recent: David S Snyder bought $12,942 on November 14, 2024.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Coya Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.